CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Pegylated interferon lambdaWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug660 Psychological and physical rehabilitation based humanistic care Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Pegylated Interferon Lambda vs. Standard Supportive Care in Subjects Infected With COVID-19

Prospective randomized trial to assess the antiviral efficacy of Pegylated Interferon Lambda (180 mcg SC injection) vs. standard of care in up to 20 inpatient subjects with COVID-19 infection.

NCT04343976 COVID-19 COVID Drug: Pegylated interferon lambda

Primary Outcomes

Description: Negative COVID PCR testing 7 days after first lambda dose

Measure: Undetectable COVID PCR at day 7

Time: 1 week

Secondary Outcomes

Description: Negative COVID PCR testing 3, 10 and 14 days after first lambda dose

Measure: Undetectable COVID PCR at day 3, 10 and 14

Time: 2 weeks

Description: Daily symptom score improvement during treatment period

Measure: Percentage of subjects on Lambda vs standard of care with symptomatic improvement

Time: 2 weeks

Description: Time to event for death, intubation, hospital discharge

Measure: Percentage of subjects on Lambda vs standard of care with improved clinical outcomes

Time: 2 weeks


No related HPO nodes (Using clinical trials)